Literature DB >> 9155713

Genetic heterogeneity in sporadic colorectal adenomas.

E Saraga1, D Bautista, G Dorta, P Chaubert, P Martin, B Sordat, P Protiva, A Blum, F Bosman, J Benhattar.   

Abstract

The majority of colorectal cancers develop from adenomatous polyps under the influence of factors that are still poorly understood. Tumourigenesis is generally considered a multistep process in which multiple genetic alterations occur, eventually reflected in abnormalities of the cellular DNA content. Macroscopical features such as tumour size and tumour architecture (tubular, tubulovillous, or villous) are correlated wit the chance of malignancy in the lesion. Grade of dysplasia can be considered an indicator for the level of progression of the adenoma towards invasive carcinoma. These characteristics were correlated with the presence or absence of K-ras mutations and the DNA ploidy in a prospective study performed on 46 large sporadic colorectal adenomas resected by endoscopy. DNA ploidy and K-ras mutations were analysed in two samples taken at distant sites in the adenomas. Aneuploidy was present in 12 adenomas (26 per cent) and K-ras mutations occurred in 26 (57 per cent). A highly significant correlation was found between aneuploidy and adenoma size, architecture, and grade of dysplasia. The presence of K-ras mutations was significantly correlated only with the size of the adenomas. The proportion of adenomas with aneuploidy and/or a K-ras mutation increased when two samples were analysed instead of one. This observation suggests that the prevalence of genetic mutations and of aneuploidy is probably underestimated, as generally only one sample is investigated. No correlation was observed between K-ras mutations and ploidy. This study demonstrates the presence of genetic heterogeneity in colorectal adenomas and supports the notion that K-ras mutation is an early event, while aneuploidy is a late event in the adenoma-carcinoma sequence.

Entities:  

Mesh:

Year:  1997        PMID: 9155713     DOI: 10.1002/(SICI)1096-9896(199703)181:3<281::AID-PATH777>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

2.  Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.

Authors:  Asier Erramuzpe; Jesús M Cortés; José I López
Journal:  Virchows Arch       Date:  2017-08-25       Impact factor: 4.064

3.  No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.

Authors:  D W Voskuil; E Kampman; W van Geloof; M Grubben; F Kok; G van Muijen; F Nagengast; H Vasen; P van't Veer
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

4.  Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.

Authors:  A Rashid; M Zahurak; S N Goodman; S R Hamilton
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

5.  Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Authors:  Margreet Lüchtenborg; Matty P Weijenberg; Petra A Wark; A Merdan Saritas; Guido M J M Roemen; Goos N P van Muijen; Adriaan P de Bruïne; Piet A van den Brandt; Anton F P M de Goeij
Journal:  BMC Cancer       Date:  2005-12-15       Impact factor: 4.430

6.  Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.

Authors:  T Tokunaga; T Tsuchida; H Kijima; K Okamoto; Y Oshika; N Sawa; Y Ohnishi; H Yamazaki; S Miura; Y Ueyama; M Nakamura
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

7.  Not infrequent K-ras mutations in depressed-type early colorectal carcinomas larger than 10 mm.

Authors:  Shinsuke Kazama; Yoichi Ajioka; Hidenobu Watanabe; Toshiaki Watanabe; Hirokazu Nagawa
Journal:  Jpn J Cancer Res       Date:  2002-02

8.  Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum.

Authors:  S Yamada; Y Ajioka; H Watanabe; H Hashidate; H Takaku; S Kazama; J Yokoyama; K Nishikura; T Fujiwara; H Asakura
Journal:  Jpn J Cancer Res       Date:  2001-02

Review 9.  Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.

Authors:  Amy L Bowes; Maxime Tarabichi; Nischalan Pillay; Peter Van Loo
Journal:  J Pathol       Date:  2022-05-23       Impact factor: 9.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.